Stockscreener 앱 받기
22.33
0.14%
-0.21
Gh Research Plc 주식(GHRS)의 최신 뉴스
(GHRS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Assessing GH Research (GHRS) Valuation After Positive Phase 2b Data For GH001 In Treatment Resistant Depression - Sahm
GH Research to Present New GH001 Phase 2b Data in Treatment-Resistant Depression at ASCP 2026 - TipRanks
GH Research (NASDAQ: GHRS) highlights Phase 2b GH001 gains in treatment-resistant depression - Stock Titan
GHRS Technical Analysis | Trend, Signals & Chart Patterns | GH RESEARCH PLC (NASDAQ:GHRS) - ChartMill
[EFFECT] GH Research PLC SEC Filing - Stock Titan
GH Research: Rapid Onset And Short Action Change The Treatment Paradigm (NASDAQ:GHRS) - Seeking Alpha
GHRS Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
H.C. Wainwright lowers GH Research stock price target on dilution By Investing.com - Investing.com South Africa
H.C. Wainwright lowers GH Research stock price target on dilution - Investing.com
Lynx1 and Weston Nichols report 17.4% stake in GH Research (NASDAQ: GHRS) - Stock Titan
Phase 2b JAMA Data and New Financing Tools Could Be A Game Changer For GH Research (GHRS) - simplywall.st
Assessing GH Research (GHRS) Valuation After Key Phase 2b Results And Phase 3 Trial Plans - Yahoo Finance
GHRS SEC FilingsGh Research Plc 10-K, 10-Q, 8-K Forms - Stock Titan
GHRS Maintained by Cantor Fitzgerald -- Price Target Raised to $35 - GuruFocus
Lynx1 discloses 15.2% stake in GHRS (GHRS) via Schedule 13G/A - Stock Titan
GHRS Maintained by CitizensPrice Target Lowered to $39.00 - GuruFocus
Cantor Fitzgerald raises GH Research stock price target on adoption outlook - Investing.com UK
These Analysts Revise Their Forecasts On GH Research After Q1 Results - Benzinga
Canaccord reiterates GH Research stock rating on phase 3 progress By Investing.com - Investing.com Nigeria
Cantor Fitzgerald raises GH Research stock price target on adoption outlook By Investing.com - Investing.com South Africa
Canaccord reiterates GH Research stock rating on phase 3 progress - Investing.com
Citizens cuts GH Research stock price target on equity financing - Investing.com
Citizens cuts GH Research stock price target on equity financing By Investing.com - Investing.com Australia
GH Research PLC announces $200 million at-the-market equity offering - Investing.com Nigeria
GH Research Launches $200 Million At-the-Market Share Offering With Stifel - TipRanks
GH Research PLC announces $200 million at-the-market equity offering By Investing.com - Investing.com South Africa
[6-K] GH Research PLC Current Report (Foreign Issuer) | GHRS SEC FilingForm 6-K - Stock Titan
GH Research Releases Q1 2026 Financial Results - AlphaStreet
GH Research PLCMay offer up to $400 million in securitiesSEC filing - marketscreener.com
Gh Research plcenters at-the-market equity offering sales agreement with StifelSEC filing - marketscreener.com
GH Research (NASDAQ: GHRS) files F-3 to register $400M in securities - Stock Titan
GH Research (NASDAQ: GHRS) launches $200M at‑the‑market share program - Stock Titan
GH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise - TipRanks
Earnings Flash (GHRS) GH Research Posts Q1 Loss $0.31 a Share, vs. FactSet Est of $0.29 Loss - marketscreener.com
GH Research Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
GH Research (Nasdaq: GHRS) widens Q1 loss but keeps $267M cash buffer - Stock Titan
GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
TradingKey - TradingKey
Experimental depression drug GH001 prepares for Phase 3 after JAMA study - Stock Titan
GH Research PLC schedules annual general meeting for June 25 in Dublin By Investing.com - Investing.com India
GH Research PLC schedules annual general meeting for June 25 in Dublin - Investing.com UK
2.25%
0.46%
자본화:
|
볼륨(24시간):